“Genetic Networks does its discovery in the primordial network conserved throughout biology. Its findings are not limited to specific diseases, drugs or targets but rather, they inform all and any of these applied areas of medicine.”
DR. LELAND HARTWELL
2001 Nobel Prize in Physiology or Medicine
Genetic Networks Co-founder
Beyond targets.
We accelerate the discovery and development of optimal candidate compounds for pre-clinical and clinical testing. Our proprietary GeneScapeTM platform enables applied modular biology and the identification of the optimal intersection between targets and compounds in specific disease spaces through whole-genome genetic perturbation and analysis.
FAST Rapid, automated, optimized robotic platform resulting in class-defining modules
UNBIASED Independent of prior knowledge as we identify and validate modules through whole-genome genetic perturbation and analysis
INFORMED Based on decades of research, expertise, and proprietary data set of thousands of screened compounds
INFORMED Based on decades of research, expertise, and proprietary data set of thousands of screened compounds
What is GeneScape?
A multi-dimensional map of diseases and drugs that integrates a genome-wide functional assay of drug activity, H-Tech, and a genome-wide functional assay of human genes and gene variants, Y-Tech, using proprietary analytics. GeneScape is unique because it is the only genome-wide functional assay for drugs that also integrates genome-wide functional data for target and disease genes. Ultimately, our clients are able to develop or repurpose drugs faster, more safely, and more cost effectively.
Why modules?
Learn more about the origins of our platform
